Article Text
Abstract
Background Obtaining informed consent in the clinical setting is an important yet challenging aspect of providing safe and collaborative care to patients. While the medical profession has defined best practices for obtaining informed consent, it is unclear whether these standards meet the expressed needs of patients, their families as well as healthcare providers. The authors sought to address this gap by comparing the responses of these three groups with a standardised informed consent paradigm.
Methods Piloting a web-based ‘reverse’ simulation paradigm, participants viewed a video showing a standardised doctor engaging in an informed consent discussion. The scenario depicted a simulated patient with psychotic symptoms who is prescribed an atypical antipsychotic medication. 107 participants accessed the simulation online and completed a web-based debriefing survey.
Results Survey responses from patients, family members and healthcare providers indicated disparities in information retention, perception of the doctor's performance and priorities for required elements of the consent process.
Conclusions To enhance existing informed consent best practices, steps should be taken to improve patient retention of critical information. Adverse events should be described in the short-term and long-term along with preventative measures, and alternative psychosocial and pharmacological treatment options should be reviewed. Information about treatment should include when the medication takes therapeutic effect and how to safely maintain the treatment. The reverse simulation design is a model that can discern gaps in clinical practice, which can be used to improve patient care.
- Computer simulation
- family
- informed consent
- patients
- psychiatry
- education
- education for healthcare professionals
- mentally ill and disabled persons
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK
- Postmortem brain donation and organ transplantation in schizophrenia: what about patient consent?
- Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials
- Effects of the combination of second-generation antipsychotics on serum concentrations of aripiprazole and dehydroaripiprazole in Chinese patients with schizophrenia
- Long term survival, health, social functioning, and education in patients with European Lyme neuroborreliosis: nationwide population based cohort study
- Comparison of prediction methods for treatment continuation of antipsychotics in children and adolescents with schizophrenia
- Dramatic weight loss associated with commencing clozapine
- Effective and safe use of intramuscular clozapine in a patient presenting with catatonia and thrombocytopenia
- Patients’ and oncologists’ perceptions towards the discussion on high-cost innovative cancer therapies: findings from a qualitative study
- Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia: a multicentre cross-sectional cohort study